The Latest Cardiac and Vascular News
SHENZHEN, China, Aug. 4, 2025 /PRNewswire/ — Pulsecare Medical, a pioneer in cardiovascular intervention technologies, announced that its innovative NxPFA™ nanosecond pulsed field ablation (ns-PFA) systemhas received marketing approval from China’s National Medical Products…
The CardioTag device fuses multiple sensing modalities to capture unique insights about the relationship between cardiac mechanics, electrical impulses, and blood flow – valuable inputs that can be used by AI algorithms to assess cardiac pressures and volume status CHICAGO–July 29, 2025–Cardiosense, a medical AI company transforming cardiovascular disease management, […]
ST. LOUIS, July 28, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its groundbreaking MAGiC Sweep™ catheter. MAGiC Sweep is the world’s first robotically navigated high-density electrophysiology (EP) mapping catheter, representing a significant advancement in the technology available to diagnose and treat complex arrhythmia patients.
July 24, 2025
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical today announced its vMap® system has been used in more than 2,000 procedures in the U.S., a milestone that underscores its rapid adoption by electrophysiologists (EPs) and hospitals seeking to improve procedural efficiency, reduce repeat interventions, and deliver better patient outcomes. As adoption of PFA accelerates, the need […]
FDA-cleared technology makes clinical-grade ECG insights for arrhythmia assessment available outside of a medical facility SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it has been awarded the Innovation Award in Remote Cardiac Diagnostics as part […]
SEOUL, South Korea, July 17, 2025 /PRNewswire/ — DeepQure announced today that South Korea’s Ministry of Food and Drug Safety (MFDS) has approved a clinical trial of HyperQure™ RDM System, the company’s novel laparoscopic renal denervation (RDN) system, for the treatment of atrial…
HOUSTON, July 17, 2025 /PRNewswire/ — Octagos, one of the fastest-growing remote cardiac monitoring platforms, today announced its selection for the Microsoft for Startups Pegasus Program – an elite, invite-only initiative for high-growth startups advancing innovation in AI, healthcare,…
July 17, 2025
New flow rate guidance designed to optimize irrigation and support consistent procedural outcomes 10,000+ VARIPULSE global procedures with low adverse event rate reinforces platform’s strong safety profile New Brunswick, NJ – July 14, 2025 – Today, Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, announced U.S. Food and Drug […]
